Intraobserver and interobserver evaluation in the radiological diagnosis of bisphosphonate-related fractures
Abstract
ObjetiveEvaluate the utility of radiography for diagnosing bisphosphonate-related atypical fractures. MethodsPatients with a subtrochanteric and diaphyseal femur fracture, admitted to the institution from 2006 to 2011, have been retrospectively reviewed. Exclusion criteria included neck, intertrochanteric and supracondylar femoral fractures, pathological fractures and paediatric patients. All clinical data of 167 patients were reviewed from case records of which 29 had a bisphosphonate-related atypical femoral fractures.Out of 169 fractures classified (including 2 bilateral patients), 109 were diaphyseal and 60 subtrochanteric.Seven MD orthopaedics divided in 3 groups reviewed all radiographs of the 169 fractures retrospectively, independently and twice. The three groups readers were different expertise levels (group 1: 3 residents in the third year; group 2: one fellowship in knee and the other one in shoulder; group 3: one expertise in hip prothesis and another in foot and ankle).The following information has been included in the readers’ data collection sheets: focal lateral cortical thickening, transverse orientation of fracture and medial spike.The three fracture characteristics were assessed as present or absent and were recorded as: YES for three criteria present, DON´T KNOW for two criteria present and NO for 0 criteria present. The intraobserver agreement was calculated with kappa coefficients while the interobserver agreement was calculated with the G-string program. The statistical analysis applied was YES for data with 3 criteria. ResultThe intraobserver agreement was kappa = 0.2 to 0.5. The Interobserver agreement was 54 % average. ConclusionRadiographs alone are not reliable enough for distinguishing complete femoral fractures related to bisphosphonate.Downloads
References
Schilcher J, Aspenberg P. Incidence of stress fractures of the femoral shaft in women treated with bisphosphonate. Acta Orthop
;80:413-5.
Bone HG, Hosking D, Devogelaer JP, Tucci JR, Emkey RD, Tonino RP, et al. Ten years’ experience with alendronate for
osteoporosis in postmenopausal women. N Engl J Med 2004;350:1189-99.
Das De S, Setiobudi T, Shen L, Das De S. A rational approach to management of alendronate-related subtrochanteric fractures.
J Bone Joint Surg Br 2010;92:679-86.
Edwards BJ, Bunta AD, Lane J, Odvina C, Rao DS, Raisch DW, et al. Bisphosphonates and nonhealing femoral fractures:
analysis of the FDA Adverse Event Reporting System (FAERS) and International Safety Efforts. J Bone Joint Surg Am
;95:297-307.
Neviaser AS, Lane JM, Lenart BA, Edobor-Osula F, Lorich DG. Low-energy femoral shaft fractures associated with alendronate
use. J Orthop Trauma 2008; 22:346-50.
Rosenberg ZS, La Rocca Vieira R, Chan SS, Babb J, Akyol Y, Rybak LD, et al. Bisphosphonate-related complete atypical
subtrochanteric femoral fractures: diagnostic utility of radiography. AJR 2011;197(4):954-60.
Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CY. Severely suppressed bone turnover: A potential complication
of alendronate therapy. J Clin Endocrinol Metab 2005;90(3):1294-1301.
Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, et al. Randomised trial of effect of alendronate on
risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 1996;348:
-41.
Nieves JW, Bilezikian JP, Lane JM, Einhorn TA, Wang Y, Steinbuch M, et al. Fragility fractures of the hip and femur: incidence
and patient characteristics. Osteoporos Int 2010;21:399-408.
Russell RG, Watts NB, Ebetino FH, Rogers MJ. Mechanisms of action of bisphosphonates: similarities and differences and their
potential influence on clinical efficacy. Osteoporos Int 2008;19:733-59
Copyright (c) 2016 Revista de la Asociación Argentina de Ortopedia y Traumatología
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Manuscript acceptance by the Journal implies the simultaneous non-submission to any other journal or publishing house. The RAAOT is under the Licencia Creative Commnos Atribución-NoComercial-Compartir Obras Derivadas Igual 4.0 Internacional (CC-BY-NC.SA 4.0) (http://creativecommons.org/licences/by-nc-sa/4.0/deed.es). Articles can be shared, copied, distributed, modified, altered, transformed into a derivative work, executed and publicly communicated, provided a) the authors and the original publication (Journal, Publisher and URL) are mentioned, b) they are not used for commercial purposes, c) the same terms of the license are maintained.
In the event that the manuscript is approved for its next publication, the authors retain the copyright and will assign to the journal the rights of publication, edition, reproduction, distribution, exhibition and communication at a national and international level in the different databases. data, repositories and portals.
It is hereby stated that the mentioned manuscript has not been published and that it is not being printed in any other national or foreign journal.
The authors hereby accept the necessary modifications, suggested by the reviewers, in order to adapt the manuscript to the style and publication rules of this Journal.
